According to filings with the U.S. Securities and Exchange Commission, HeartFlow is raising $215,855,148.00 in new funding. Sources indicate that as part of senior management Chief Financial Officer, Monica Tellado played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About HeartFlow
HeartFlow is a medical technology company transforming the way cardiovascular disease is diagnosed and treated. With our HeartFlow Analysis, a non-invasive personalized cardiac test, physicians are able to make better care decisions for their patients with suspected coronary artery disease–the number one killer of men and women worldwide. HeartFlow is backed by decades of scientific research and development and leverages the latest advancements in technology to help set a new standard of care for diagnosing cardiovascular care worldwide. Cleared for use in the United States, Canada, Europe and Japan and with offices in Redwood City, Austin, London and Japan, HeartFlows footprint is growing rapidly. HeartFlow has received more than $240 million dollars in funding in a recent Series E financing round, is pre-IPO and leverages the latest technology including deep learning and computational fluid dynamics. We try to embody the best of both technology and healthcare companies and hire people who are passionate about living our mission to save lives, improve the patient experience and reduce the overall cost of care.

To learn more about HeartFlow, visit http://www.heartflow.com/

Contact:
Monica Tellado, Chief Financial Officer
650-241-1221

SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.